PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer

類似資料

• The clinical utility of PD-L1 testing in selecting non-small cell lung cancer patients for PD1/PD-L1 directed therapy
  著者:: Villaruz, Liza C., 等
  出版事項: (2016)
• Temsirolimus therapy in a patient with lung adenocarcinoma harboring an FBXW7 mutation
  著者:: Villaruz, Liza C., 等
  出版事項: (2013)
• Personalized Therapy for Non-Small Cell Lung Cancer: Which Drug for Which Patient?
  著者:: Villaruz, Liza C., 等
  出版事項: (2011)
• Identification of PD-L1-related biomarkers for selecting gastric adenocarcinoma patients for PD-1/PD-L1 inhibitor therapy
  著者:: Bo-Ya Li, 等
  出版事項: (2025-05-01)
• Personalizing Therapy in Advanced Non–Small Cell Lung Cancer
  著者:: Villaruz, Liza C., 等
  出版事項: (2013)